4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank88
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-187.24%
↑ 100% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-57081.50%
Historical baseline
PeriodValueYoY Change
2025-187.24%+100.0%
2024-507678.38%-93112.5%
2023-544.65%+84.5%
2022-3516.52%-789.2%
2021-395.46%+5.0%
2020-416.28%+42.7%
2019-726.65%-887.4%
2018-73.60%+62.2%
2017-194.68%-